These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8646274)

  • 21. Clozapine Rechallenge After Neutropenia or Leucopenia.
    Prokopez CR; Armesto AR; Gil Aguer MF; Balda MV; Papale RM; Bignone IM; Daray FM
    J Clin Psychopharmacol; 2016 Aug; 36(4):377-80. PubMed ID: 27232877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine toxicity due to a multiple drug interaction: a case report.
    Cadeddu G; Deidda A; Stochino ME; Velluti N; Burrai C; Del Zompo M
    J Med Case Rep; 2015 Apr; 9():77. PubMed ID: 25890012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful re-exposure to clozapine following uneventful rechallenge with olanzapine in a patient with neutropenia related to both agents.
    Wu SY; Liu CC; Hsieh MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1089-90. PubMed ID: 18407390
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMS after clozapine initiation.
    Skarpathiotakis M; Westreich N
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
    [No Abstract]   [Full Text] [Related]  

  • 26. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of late-onset angioedema associated with clozapine and redevelopment of angioedema with olanzapine.
    Tatar ZB; Oflaz S; Baran B
    J Clin Psychopharmacol; 2014 Aug; 34(4):523-5. PubMed ID: 24911442
    [No Abstract]   [Full Text] [Related]  

  • 28. Delirium with anticholinergic symptoms after a combination of paliperidone and olanzapine pamoate in a patient known to smoke cannabis: an unfortunate coincidence.
    Kokalj A; Rijavec N; Tavčar R
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent clonazepam withdrawal delirium in a postoperative neurosurgical patient: a case report.
    Lutz EW; Hines C
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34162601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olanzapine may cause delirium in geriatric patients.
    Samuels S; Fang M
    J Clin Psychiatry; 2004 Apr; 65(4):582-3. PubMed ID: 15119927
    [No Abstract]   [Full Text] [Related]  

  • 31. [Delirium due to increase in clozapine level during an inflammatory reaction].
    van der Molen-Eijgenraam M; Blanken-Meijs JT; Heeringa M; van Grootheest AC
    Ned Tijdschr Geneeskd; 2001 Mar; 145(9):427-30. PubMed ID: 11253499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient.
    Hail SL; Obafemi A; Kleinschmidt KC
    Clin Toxicol (Phila); 2013 Mar; 51(3):162-6. PubMed ID: 23473460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
    Sayin A; Cosar B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
    Huang TL
    Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
    van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
    J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW; Bogers JP; Giltay EJ
    Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolongation of clozapine-induced neutropenia with olanzapine.
    Jagadheesan K; Mehrtens J
    Aust N Z J Psychiatry; 2007 Feb; 41(2):192. PubMed ID: 17464699
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postinjection Delirium Syndrome Associated With Olanzapine Long-Acting Injectable.
    Bengtsson C; Nilsson BM; Bodén R
    J Clin Psychopharmacol; 2016 Aug; 36(4):388-9. PubMed ID: 27159773
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.